Cargando…
Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
Idiopathic pulmonary fibrosis (IPF) is one of the most common and devastating interstitial lung diseases with poor prognosis. Currently, few effective drugs are available for IPF. Hence, we sought to explore the role of mefunidone (MFD), a newly synthesized drug developed by our team, in lung fibros...
Autores principales: | Han, Yuanyuan, Jiang, Mao, He, Rongling, Lv, Xin, Liao, Xiaohua, He, Yijun, Zhang, Fan, Long, Lingzhi, Jiang, Guoliang, Peng, Zhangzhe, Tao, Lijian, Hu, Gaoyun, Meng, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499630/ https://www.ncbi.nlm.nih.gov/pubmed/34630088 http://dx.doi.org/10.3389/fphar.2021.713572 |
Ejemplares similares
-
Protective effects of mefunidone on ischemia-reperfusion injury/Folic acid-induced acute kidney injury
por: Li, Jiajia, et al.
Publicado: (2022) -
Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury
por: Li, Jiajia, et al.
Publicado: (2023) -
Mefunidone Attenuates Tubulointerstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction
por: Liu, Chunyan, et al.
Publicado: (2015) -
Protective Effect of Fluorofenidone Against Acute Lung Injury Through Suppressing the MAPK/NF-κB Pathway
por: Lv, Xin, et al.
Publicado: (2021) -
Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway
por: Dai, Qin, et al.
Publicado: (2020)